Epigral (NSE:EPIGRAL) Beneish M-Score: -1.78 (As of Jun. 28, 2026)


NSE:EPIGRAL Epigral Ltd NSE:EPIGRAL
86 GF Score
Price ₹1,106.20
GF Value ₹1,754.72
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Epigral Beneish M-Score?

Epigral NSE:EPIGRAL -2.07% 86 Beneish M-Score is -1.78 as of Jun. 28, 2026. GuruFocus rates NSE:EPIGRAL with a GF Score™ of 86/100 and a GF Value™ of ₹1,754.72 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,526 Chemicals companies, Epigral ranks worse than 85.26% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.78 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Epigral's Beneish M-Score or its related term are showing as below:

NSE:EPIGRAL' s Beneish M-Score Range Over the Past 10 Years
Min: -2.95   Med: -2.32   Max: -0.61
Current: -1.78

During the past 9 years, the highest Beneish M-Score of Epigral was -0.61. The lowest was -2.95. And the median was -2.32.


Epigral Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Epigral's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epigral Beneish M-Score Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -1.83 -2.95 -2.58 -2.32 -1.78

Epigral Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 0.00 0.00 0.00 -1.78

NSE:EPIGRAL vs DOW: Beneish M-Score Comparison

For the Chemicals subindustry, Epigral's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigral Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Epigral's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Epigral's Beneish M-Score falls into.


NSE:EPIGRAL
86GF Score
Epigral Ltd NSE:EPIGRAL
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epigral Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Epigral for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.582+0.528 * 1.0981+0.404 * 1.5233+0.892 * 0.9925+0.115 * 0.8816
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6593+4.679 * -0.029544-0.327 * 0.993
=-1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹4,223 Mil.
Revenue was ₹24,955 Mil.
Gross Profit was ₹9,988 Mil.
Total Current Assets was ₹8,267 Mil.
Total Assets was ₹35,053 Mil.
Property, Plant and Equipment(Net PPE) was ₹25,670 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,683 Mil.
Selling, General, & Admin. Expense(SGA) was ₹328 Mil.
Total Current Liabilities was ₹7,104 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3,362 Mil.
Net Income was ₹3,320 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹4,355 Mil.
Total Receivables was ₹2,690 Mil.
Revenue was ₹25,144 Mil.
Gross Profit was ₹11,051 Mil.
Total Current Assets was ₹7,752 Mil.
Total Assets was ₹31,524 Mil.
Property, Plant and Equipment(Net PPE) was ₹23,113 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,326 Mil.
Selling, General, & Admin. Expense(SGA) was ₹501 Mil.
Total Current Liabilities was ₹4,956 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4,523 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4223.4 / 24954.8) / (2689.9 / 25144)
=0.169242 / 0.10698
=1.582

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11051 / 25144) / (9987.7 / 24954.8)
=0.439508 / 0.400232
=1.0981

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (8266.9 + 25669.9) / 35053) / (1 - (7752.4 + 23113) / 31524.4)
=0.031843 / 0.020904
=1.5233

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=24954.8 / 25144
=0.9925

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1325.6 / (1325.6 + 23113)) / (1682.9 / (1682.9 + 25669.9))
=0.054242 / 0.061526
=0.8816

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(328.1 / 24954.8) / (501.4 / 25144)
=0.013148 / 0.019941
=0.6593

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3362.1 + 7104.2) / 35053) / ((4523.4 + 4955.9) / 31524.4)
=0.298585 / 0.300697
=0.993

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3319.7 - 0 - 4355.3) / 35053
=-0.029544

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Epigral has a M-score of -1.78 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.78 mean?
Epigral (NSE:EPIGRAL) has a Beneish M-Score of -1.78 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Epigral and its competitors. According to the industry distribution chart, Epigral ranks #1301 out of 1526 companies in the Chemicals industry, placing it in the top 85.3%.
Is Epigral's Beneish M-Score too high?
Epigral's current Beneish M-Score is -1.78. Based on the distribution chart, Epigral ranks #1301 out of 1526 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Epigral has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Epigral's Beneish M-Score compare to DOW?
According to the Chemicals industry distribution chart, Epigral ranks #1301 out of 1526 companies for Beneish M-Score. This places Epigral in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Epigral and its competitors. Epigral's current Beneish M-Score is -1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epigral stock overvalued right now?
Based on GuruFocus' analysis, Epigral (NSE:EPIGRAL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,754.72, compared to a current price of ₹1,106.20 — trading 37% below its estimated fair value. The current Beneish M-Score is -1.78. Epigral's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Epigral (NSE:EPIGRAL), the current Beneish M-Score is -1.78 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Epigral (NSE:EPIGRAL) Overvalued in 2026?

Based on GuruFocus' analysis, Epigral stock appears to be undervalued. The current stock price of ₹1,106.20 is trading 37% below its estimated GF Value™ of ₹1,754.72. GuruFocus considers Epigral to be Significantly Undervalued.

Key valuation signals for NSE:EPIGRAL:

  • Beneish M-Score: -1.78
  • GF Value™: ₹1,754.72 vs. price of ₹1,106.20 (37% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the NSE:EPIGRAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Epigral Business Description

Other Exchanges 543332:India
Address Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.
86GF Score

Get the complete analysis for NSE:EPIGRAL

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,106.20
Price
₹1,754.72
GF Value